Results 71 to 80 of about 5,346,158 (173)

Blastic plasmacytoid dendritic cell neoplasm: an early presentation [PDF]

, 2019
A blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a cutaneous lymphoma derived from a plasmacytoid dendritic precursor cell that exhibits aggressive clinical behavior. Herein, we report a 46-year-old woman with a complaint of a painless nodule on
Dias Júnior, Leônidas Braga, Palheta, Caroline da Silva Alves, Brito, Caio Vinicius Botelho, Fernandes, Cassia Michelle Almeida, Einecke, Yandra Sherring, Carneiro, Francisca Regina Oliveira, Silveira, Samira Oliveira, Pinto, Érica Baptista, Érica Baptista Pinto, Leônidas Braga Dias Júnior, Francisca Regina Oliveira Carneiro, Yandra Sherring Einecke, Cassia Michelle Almeida Fernandes, Silveira, Samira Oliveira ; Fernandes, Cassia Michelle Almeida ; Pinto, Érica Baptista ; Einecke, Yandra Sherring ; Palheta, Caroline da Silva Alves ; Brito, Caio Vinicius Botelho ; Dias Júnior, Leônidas Braga ; Carneiro, Francisca Regina Oliveira, Samira Oliveira Silveira, Caroline da Silva Alves Palheta, Caio Vinicius Botelho Brito   +16 more
core   +1 more source

Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm

, 2023
Venetoclax is an approved treatment for relapsed/refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). We report a unique case of venetoclax monotherapy used for front-line induction and as a bridge to allogeneic hematopoietic stem cell ...
Ankit Mitesh Shah, Poveda, Julio, Shah, Ankit Mitesh, Pereira, Denise, Julio Poveda, Wang, Trent Peng, Denise Pereira, Trent Peng Wang   +7 more
core   +1 more source

Genetic analysis of primary lung interdigitating dendritic cell sarcomas

The Journal of Pathology, Volume 269, Issue 4-5, Page 387-398, August 2026.
Abstract Interdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy‐number alterations (CNAs) in nine IDCSs arising in the lung by ...
Mikhail S Ermakov, Juliana Faria Filipe, Sylvia Eidenhammer, German Ott, Iris Halbwedl, Karl Kashofer, Helmut Popper   +6 more
wiley   +1 more source

Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies

International Journal of Laboratory Hematology, Volume 48, Issue 4, Page 795-806, August 2026.
ABSTRACT Introduction Neutrophil‐extracellular traps are net‐like material released by triggered neutrophils and composed of decondensed chromatin linked to nuclear proteins. Elastase, one of the fourth most represented neutrophil‐specific serine proteases stored in azurophil granules of naïve neutrophils, exerts various actions, including degradation ...
Pasqualina Scala, Anna Maria Della Corte, Angela Bertolini, Marisa Gorrese, Francesca Picone, Bianca Serio, Danilo De Novellis, Laura Mettivier, Luca Pezzullo, Maria Carmen Martorelli, Denise Morini, Matteo D'Addona, Bianca Cuffa, Carmine Selleri, Valentina Giudice   +14 more
wiley   +1 more source

Acute Myeloid Leukemia With Florid Plasmacytoid Dendritic Cell Expansion and Aberrant Expression of CD19

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 919-920, October 2026.
Afshin Shameli, Russell K. Dorer
wiley   +1 more source

Blastic plasmacytoid dendritic neoplasm / Nabia Idaam Mustapa Albakari [PDF]

, 2018
Blastic plasmacytoid dendritic neoplasm (BPCDN) is a rare entity and difficult to diagnose. It is highly aggressive with a poor diagnosis. Early diagnosis may help with treatment.
Mustapa Albakari, Nabia Idaam
core  

Anti‐BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma

HemaSphere, Volume 10, Issue 8, August 2026.
Ondrej Venglar, Eva Radova, Maxima Warmuzova, Daniel Bilek, Marketa Kudelkova, Katerina Jasinkova, Ludmila Muronova, Lucie Broskevicova, Veronika Kapustova, Jan Vrana, Tereza Novakova, Katerina Karasova, Michaela Hornakova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michal Simicek, Jakub Radocha, Tereza Sevcikova, David Zihala, Juli Bago, Roman Hajek, Tomas Jelinek   +22 more
wiley   +1 more source

An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor

Case Reports in Pathology, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells that represent less than 1% of hematological malignancies.
Daniel M. Pak, Maria S. Tretiakova
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm

Kansas Journal of Medicine, 2014
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It manifests as cutaneous and bone marrow involvement and leukemic spread. It represents 0.7% of primary cutaneous lymphomas. Recently, it was established as a distinct entity.
Rami Jabbour, Jimmy Doumit, Janah Maddah, Fady Nasr   +3 more
openaire   +2 more sources

Blastic plasmacytoid dendritic cell neoplasm in an elderly woman

, 2013
Blastic plasmacytoid dendritic cell neoplasm (a.k.a. NK cell lymphoma, CD4+CD56+ haematodermic neoplasm) is a rare aggressive tumour that arises from plasmacytoid dendritic cell precursors.
Fazril Zayadi
core